This article utilizes a purposive sampling method to explored Chronic Hepatitis C (CHC) positive patients receiving antiviral therapy treatment from liver clinics from two tertiary hospitals located in Sidney, Australia. Several factors were explored including the influences that triggered the patient to start receiving antiviral treatment, ability to adhere to the treatment plan, and how successful treatment completion was achieved. The authors believe that as new CHC treatments become available, adherence to treatment therapies will become more important. As therapies progress identifying potential patients that may need additional treatment support will be essential in treatment success. Future treatments will become more refined, affordable,
